Richard F. Olsson - Concepedia

Author

Richard F. Olsson

Also Known As

Artz, Andrew S., Battiwalla, Minoo, Hale, Gregory A., Holmberg, Leona A., Kamani, Nayesh R., Kitko, Carrie L., Lazarus, Hillard M., Olsson, Richard F, R F Olsson, R OLSSON

206

Publications

7.9K

Citations

H-Index

Concepts

All Affiliations

Karolinska Institutet Medical College of Wisconsin Uppsala University Vanderbilt University Medical Center The University of Texas MD Anderson Cancer Center

About

Richard F. Olsson is an author at Karolinska Institutet specializing in medicine, hematology, and transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	36	2K
2	Health Sciences	7	7	328
3	Engineering	2	2	29
4	Natural Sciences	2	2	52
5	Public Health	2	2	61

Richard F. Olsson

122

Publications

7.5K

Citations

H-Index

Page 1

	Year	Citations
Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research Sally Arai, Mukta Arora, Tao Wang, Biology of Blood and Marrow Transplantation	2014	429
Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial William W. Busse, Eugene R. Bleecker, J Mark FitzGerald, The Lancet Respiratory Medicine AsthmaRheumatologyExtension TrialAllergyAllergy Medicine	2018	298
Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States Lori Muffly, Marcelo C. Pasquini, Michael J. Martens, Blood	2017	281
Graft failure in the modern era of allogeneic hematopoietic SCT Richard F. Olsson, Mats Remberger, M. Schaffer, Bone Marrow Transplantation TransplantationMarrow TransplantationStem Cell TransplantationHematologyGraft Survival	2012	275
Reduced-intensity transplantation for lymphomas using haploidentical related donors vs HLA-matched unrelated donors Abraham S. Kanate, Alberto Mussetti, Mohamed A. Kharfan‐Dabaja, Blood	2015	271
Reduced Intensity Conditioning Compared With Myeloablative Conditioning Using Unrelated Donor Transplants in Patients With Acute Myeloid Leukemia Olle Ringdén, Myriam Labopin, Gerhard Ehninger, Journal of Clinical Oncology	2009	268
Improved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research Study Anita D’Souza, Angela Dispenzieri, Baldeep Wirk, Journal of Clinical Oncology	2015	200
Impact of Conditioning Regimen on Outcomes for Patients with Lymphoma Undergoing High-Dose Therapy with Autologous Hematopoietic Cell Transplantation Yi‐Bin Chen, Andrew A. Lane, Brent R. Logan, Biology of Blood and Marrow Transplantation	2015	156
Early Failure of Frontline Rituximab-Containing Chemo-immunotherapy in Diffuse Large B Cell Lymphoma Does Not Predict Futility of Autologous Hematopoietic Cell Transplantation Mehdi Hamadani, Parameswaran Hari, Ying Zhang, Biology of Blood and Marrow Transplantation	2014	145
Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies Richard F. Olsson, Brent R. Logan, Sonali Chaudhury, Leukemia Radiation OncologyTransplantationMarrow TransplantationStem Cell TransplantationImmunology	2015	138

Page 1